Cargando…
Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
Many neurodegenerative diseases are characterized by the conformational change of normal self-proteins into amyloidogenic, pathological conformers, which share structural properties such as high β-sheet content and resistance to degradation. The most common is Alzheimer's disease (AD) where the...
Autores principales: | Goñi, Fernando, Prelli, Frances, Ji, Yong, Scholtzova, Henrieta, Yang, Jing, Sun, Yanjie, Liang, Feng-Xia, Kascsak, Regina, Kascsak, Richard, Mehta, Pankaj, Wisniewski, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954195/ https://www.ncbi.nlm.nih.gov/pubmed/20967130 http://dx.doi.org/10.1371/journal.pone.0013391 |
Ejemplares similares
-
Anti-PrP(C )monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
por: Chung, Erika, et al.
Publicado: (2010) -
Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation
por: Scholtzova, Henrieta, et al.
Publicado: (2014) -
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
por: Herline, Krystal, et al.
Publicado: (2018) -
Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
por: Goñi, Fernando, et al.
Publicado: (2013) -
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
por: Goñi, Fernando, et al.
Publicado: (2018)